SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000921895-24-000071
Filing Date
2024-01-09
Accepted
2024-01-09 16:49:08
Documents
1
Period of Report
2024-01-05

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form407422010_01092024.html 4  
1 OWNERSHIP DOCUMENT form407422010_01092024.xml 4 31675
  Complete submission text file 0000921895-24-000071.txt   38449
Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Reporting) CIK: 0000918923 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39460 | Film No.: 24523844
SIC: 6282 Investment Advice
(CF Office: 02 Finance)

Mailing Address 44 MONTGOMERY ST. 40TH FLOOR SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY ST. 40TH FLOOR SAN FRANCISCO CA 94104 3125066500
BVF PARTNERS L P/IL (Reporting) CIK: 0001055947 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39460 | Film No.: 24523845

Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500
BVF INC/IL (Reporting) CIK: 0001056807 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39460 | Film No.: 24523847

Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND II LP (Reporting) CIK: 0001102444 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39460 | Film No.: 24523852

Mailing Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104
Business Address
LAMPERT MARK N (Reporting) CIK: 0001233840 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39460 | Film No.: 24523846

Mailing Address P.O. BOX 309 UGLAND HOUSE GRAND CAYMAN E9 KY1-1104
Business Address P.O. BOX 309 UGLAND HOUSE GRAND CAYMAN E9 KY1-1104 (415) 525-8890
Biotechnology Value Trading Fund OS LP (Reporting) CIK: 0001660683 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39460 | Film No.: 24523850

Mailing Address P.O. BOX 309 UGLAND HOUSE GRAND CAYMAN E9 KY1-1104
Business Address P.O. BOX 309 UGLAND HOUSE GRAND CAYMAN E9 KY1-1104 (415) 525-8890
BVF Partners OS Ltd. (Reporting) CIK: 0001660684 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39460 | Film No.: 24523849

Mailing Address 44 MONTGOMERY ST., 40TH FLOOR SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY ST., 40TH FLOOR SAN FRANCISCO CA 94104 415-525-8830
BVF I GP LLC (Reporting) CIK: 0001803805 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39460 | Film No.: 24523853

Mailing Address 44 MONTGOMERY ST., 40TH FLOOR SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY ST., 40TH FLOOR SAN FRANCISCO CA 94104 415-525-8830
BVF II GP LLC (Reporting) CIK: 0001803806 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39460 | Film No.: 24523851

Mailing Address 44 MONTGOMERY ST., 40TH FLOOR SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY ST., 40TH FLOOR SAN FRANCISCO CA 94104 415-525-8830
BVF GP HOLDINGS LLC (Reporting) CIK: 0001803809 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39460 | Film No.: 24523848

Mailing Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472
Business Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Issuer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)